版本:
中国

BRIEF-Mallinckrodt enrolls first patient in Phase 2B trial of H.P. acthar gel

June 14 Mallinckrodt Plc

* Mallinckrodt enrolls first patient in Phase 2B trial of H.P. Acthar® gel (repository corticotropin injection) for amyotrophic lateral sclerosis (ALS) Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐